Drospirenone is a novel progestogen that possesses antimineralocorticoid activity. This
activity is seen clinically in its effects on physiological parameters, body weight, general well …

Progesterone has a high affinity for the mineralocorticoid receptor and is an antagonist of
aldosterone. Almost all synthetic progestogens are devoid of an antimineralocorticoid effect …

Low-dose combined oral contraceptives are generally well tolerated and represent an
excellent reversible form of contraception that is suitable for most women. Certain aspects of …

The spironolactone derivative drospirenone is combined with ethinylestradiol or estetrol in
combined oral contraceptives. Formulations with 17-β-estradiol are used to treat climacteric …

PURPOSE: Positive effects on premenstrual symptoms have been observed with low-dose
oral contraceptives. Drospirenone is a synthetic progestogen with antiandrogenic and …

Objectives To describe the effects of low-dose hormonal replacement therapy (HRT) on
quality of life, metabolic parameters and blood pressure in postmenopausal women …

Oral contraception is the most widely used reversible contraceptive method. Continuous
research over the past decades has led to a range of highly reliable, effective and safe oral …

Background: Drospirenone, a novel synthetic progestin, possesses characteristics more like
natural progesterone than other synthetic progestins, such as medroxyprogesterone acetate …

Drospirenone 3mg with ethinylestradiol 20µg (Yaz®) is a low-dose combined oral
contraceptive (COC) administered in a regimen of 24 days of active tablets followed by a …

Considerable advances have been made in the field of combined oral contraceptives since
their introduction 50 years ago. This ongoing evolution has been focused on reducing the …